ArticleCureus2026

Bioequivalence of Fixed-Dose Dapagliflozin-Pioglitazone in Healthy Indian Adults: Results From the Randomized Crossover PRO-4 Study.

J Hari Prasath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.